AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
RECURRENT TOXIC SHOCK-LIKE ILLNESS ASSOCIATED WITH MENSES - REPLY
Authors: VERBON A FISHER CJ
Citation: A. Verbon et Cj. Fisher, RECURRENT TOXIC SHOCK-LIKE ILLNESS ASSOCIATED WITH MENSES - REPLY, Clinical infectious diseases, 26(1), 1998, pp. 252-253
NON-DIPOLE PHOTOEMISSION EFFECTS IN X-RAY STANDING WAVE-FIELD DETERMINATION OF SURFACE-STRUCTURE
Authors: FISHER CJ ITHIN R JONES RG JACKSON GJ WOODRUFF DP COWIE BCC
Citation: Cj. Fisher et al., NON-DIPOLE PHOTOEMISSION EFFECTS IN X-RAY STANDING WAVE-FIELD DETERMINATION OF SURFACE-STRUCTURE, Journal of physics. Condensed matter, 10(35), 1998, pp. 623-629
INTERLEUKIN-10 (IL-10) MEDIATED INHIBITION OF INFLAMMATORY CYTOKINES BY HUMAN ALVEOLAR MACROPHAGE INVOLVES NUCLEAR FACTOR-KAPPA-B
Authors: THOMASSEN MJ RAYCHAUDHURI B CONNORS MJ BUHROW L MALUR A FISHER CJ
Citation: Mj. Thomassen et al., INTERLEUKIN-10 (IL-10) MEDIATED INHIBITION OF INFLAMMATORY CYTOKINES BY HUMAN ALVEOLAR MACROPHAGE INVOLVES NUCLEAR FACTOR-KAPPA-B, Journal of leukocyte biology, 1998, pp. 18-18
SEVERE RECALCITRANT ERYTHEMATOUS DESQUAMATING DISORDER ASSOCIATED WITH FATAL RECURRENT TOXIC SHOCK SYNDROME IN A PATIENT WITHOUT AIDS
Authors: VERBON A FISHER CJ
Citation: A. Verbon et Cj. Fisher, SEVERE RECALCITRANT ERYTHEMATOUS DESQUAMATING DISORDER ASSOCIATED WITH FATAL RECURRENT TOXIC SHOCK SYNDROME IN A PATIENT WITHOUT AIDS, Clinical infectious diseases, 24(6), 1997, pp. 1274-1275
NEW VARIANT CRUTZFELDT-JAKOB-DISEASE - PSYCHIATRIC FEATURES
Authors: ZEIDLER M JOHNSTONE EC BAMBER RWK DICKENS CM FISHER CJ FRANCIS AF GOLDBECK R HIGGO R JOHNSONSABINE EC LODGE GJ MCGARRY P MITCHELL S TARLO L TURNER M RYLEY P WILL RG
Citation: M. Zeidler et al., NEW VARIANT CRUTZFELDT-JAKOB-DISEASE - PSYCHIATRIC FEATURES, Lancet, 350(9082), 1997, pp. 908-910
CONFIRMATORY INTERLEUKIN-1 RECEPTOR ANTAGONIST TRIAL IN SEVERE SEPSIS- A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL
Authors: OPAL SM FISHER CJ DHAINAUT JFA VINCENT JL BRASE R LOWRY SF SADOFF JC SLOTMAN GJ LEVY H BALK RA SHELLY MP PRIBBLE JP LABRECQUE JF LOOKABAUGH J DONOVAN H DUBIN H BAUGHMAN R NORMAN J DEMARIA E MATZEL K ABRAHAM E SENEFF M BARBER A BRAYMAN K CERRA F CHALFIN D CHAZEN G CHRISTOU N COONEY R CORBIN R DREW R EMMANUEL G PINES B ERON L FLETCHER R FOULKE G GALLAGHER T GERVICH D GROSSMAN J HALPERN N HANNA C JOHNSON S KUBAK B LODATO R LOVETT M MARSHALL J METZLER M NELSON L FREELAND M OROPELLO J PAZ H RACKOW E RIKER R RISSING P SCHEIN R SCHELD M SCHUSTER D SIBBALD W SILVERMAN H SOMERMEYER M STRANGE C SUMMER W TOPIEL M WHITE J ALESTIG K ANDERSEN PK ANDERSSON J BENNETT D BERG S BLEICHNER G BRUNET F CARLET J DEJONG MJ DREXLER H GARRARD C HESLET L KLOSS T PAUL W REINHART K RENAUD B RITZ R ROMME JH SCHMITZ JE STOCKENHUBER F SUTER P TENAILLON A VAGT A VANDERMEER WM VANDEVENTER S VANLEEUWEN PAM VERHOEF J WEBSTER N WINTER RJ WOLFF M STILES DM DEVOS A CROFT C FAZIO J THOMPSON R WIEDEMANN H ELLISON RT CHINCHILLI VM YARBOROUGH M
Citation: Sm. Opal et al., CONFIRMATORY INTERLEUKIN-1 RECEPTOR ANTAGONIST TRIAL IN SEVERE SEPSIS- A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL, Critical care medicine, 25(7), 1997, pp. 1115-1124
INFLUENCE OF ALTERATIONS IN FORGOING LIFE-SUSTAINING TREATMENT PRACTICES ON A CLINICAL SEPSIS TRIAL (VOL 25, PG 386, 1997)
Authors: SPRUNG CL EIDELMAN LA PIZOV R FISHER CJ ZIEGLER EJ SADOFF JC STRAUBE RC MCCLOSKEY RV
Citation: Cl. Sprung et al., INFLUENCE OF ALTERATIONS IN FORGOING LIFE-SUSTAINING TREATMENT PRACTICES ON A CLINICAL SEPSIS TRIAL (VOL 25, PG 386, 1997), Critical care medicine, 25(6), 1997, pp. 1092-1092
INFLUENCE OF ALTERATIONS IN FORGOING LIFE-SUSTAINING TREATMENT PRACTICES ON A CLINICAL SEPSIS TRIAL
Authors: SPRUNG CL EIDELMAN LA PIZOV R FISHER CJ ZIEGLER EJ SADOFF JC STRAUBE RC MCCLOSKEY RV
Citation: Cl. Sprung et al., INFLUENCE OF ALTERATIONS IN FORGOING LIFE-SUSTAINING TREATMENT PRACTICES ON A CLINICAL SEPSIS TRIAL, Critical care medicine, 25(3), 1997, pp. 383-387
FROM THE BENCH TO THE BEDSIDE - THE FUTURE OF SEPSIS RESEARCH
Authors: DELLINGER RP OPAL SM ROTROSEN D SUFFREDINI AF ZIMMERMAN JL BONE RC BOSKEN CH DELLINGER P GOLDSTEIN RA HURD S VINCENT JL ABRAHAM E ADAMS HR ARTIGAS A BALK RA BERNARD GR BEUTLER B COHEN J COOK DJ DANNER RL DORINSKI PM FISHER CJ FINK MP GLAUSER MP HARKINS R LAUCHENBRUCH P MUNFORD RS NATANSON C NELSON S PARRILLO JE PENNINGTON JE ROBERTS R SIBBALD WJ SIEGEL JN STRAUBE RC TERES D ULEVITCH RJ VOGEL S WARREN S WRIGHT SD
Citation: Rp. Dellinger et al., FROM THE BENCH TO THE BEDSIDE - THE FUTURE OF SEPSIS RESEARCH, Chest, 111(3), 1997, pp. 744-753
HISTOPATHOLOGY OF BREAST-CANCER IN RELATION TO AGE
Authors: FISHER CJ EGAN MK SMITH P WICKS K MILLIS RR FENTIMAN IS
Citation: Cj. Fisher et al., HISTOPATHOLOGY OF BREAST-CANCER IN RELATION TO AGE, British Journal of Cancer, 75(4), 1997, pp. 593-596
INTERLEUKIN-10 (IL-10) MODULATES SUPERANTIGEN INDUCED CYTOKINE PRODUCTION BY HUMAN ALVEOLAR MACROPHAGES
Authors: THOMASSEN MJ BUHROW LT FISHER CJ
Citation: Mj. Thomassen et al., INTERLEUKIN-10 (IL-10) MODULATES SUPERANTIGEN INDUCED CYTOKINE PRODUCTION BY HUMAN ALVEOLAR MACROPHAGES, Molecular biology of the cell, 7, 1996, pp. 842-842
NEAR-ELECTRODE MODEL FOR 100-STANDARD ATMOSPHERE ARE DISCHARGES
Authors: FELDERMAN EJ MACDERMOTT WN FISHER CJ
Citation: Ej. Felderman et al., NEAR-ELECTRODE MODEL FOR 100-STANDARD ATMOSPHERE ARE DISCHARGES, Journal of propulsion and power, 12(6), 1996, pp. 1084-1092
POTENTIAL STRATEGIES FOR INFLAMMATORY MEDIATOR MANIPULATION - RETROSPECT AND PROSPECT
Authors: FISHER CJ ZHENG YL
Citation: Cj. Fisher et Yl. Zheng, POTENTIAL STRATEGIES FOR INFLAMMATORY MEDIATOR MANIPULATION - RETROSPECT AND PROSPECT, World journal of surgery, 20(4), 1996, pp. 447-453
USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS
Authors: KNAUS WA HARRELL FE LABRECQUE JF WAGNER DP PRIBBLE JP DRAPER EA FISHER CJ SOLL L ASTIZ M RACKOW EC CARPATI C BALK RA FRIEDMAN B MURE AJ SHAPIRO E MELHOM L SHAPIRO MJ TAYLOR R KEEGAN M OBRIEN J GREENMAN RL SCHEIN R PENA M WASSERLOUF M IBERTI TJ OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAN N MERRICK DK BERQUIST W MATZEL K HUEBLER M FOULKE G ALBERTSON T WALBY W ALLEN R BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMAS BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C GERVICH D BRASE R BAGDAHN A COONEY R SMITH JS VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN H DURKIN M STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUVEN PAM BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL J KRUGER R DRUMMOND A FISHER CS LANGE P SELFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY S COYLE SM BARIE PS DEMARIA E REINES HD SNYDMAN D SCHWAITZBERG S NASRAWAY S GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D BLEICHNER G DAHN M HALL J WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J SHELLY MP NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON G SENEFF M CONRY K ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D LAURELL MH JACOBS S ASH S OPAL SM SLOTMAN GJ IBERTI TJ SADOFF JC STILES DM THOMPSON B PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDMAN H WITTES J THOMPSON BW LABRECQUE JF CATALANO MA CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Wa. Knaus et al., USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS, Critical care medicine, 24(1), 1996, pp. 46-56
REGULATION OF HUMAN ALVEOLAR MACROPHAGE INFLAMMATORY CYTOKINE PRODUCTION BY INTERLEUKIN-10
Authors: THOMASSEN MJ DIVIS LT FISHER CJ
Citation: Mj. Thomassen et al., REGULATION OF HUMAN ALVEOLAR MACROPHAGE INFLAMMATORY CYTOKINE PRODUCTION BY INTERLEUKIN-10, Clinical immunology and immunopathology, 80(3), 1996, pp. 321-324
TUMOR-NECROSIS-FACTOR RECEPTOR-FC FUSION PROTEIN IN SEPTIC SHOCK - REPLY
Authors: FISHER CJ AGOSTI JM OPAL SM
Citation: Cj. Fisher et al., TUMOR-NECROSIS-FACTOR RECEPTOR-FC FUSION PROTEIN IN SEPTIC SHOCK - REPLY, The New England journal of medicine, 335(21), 1996, pp. 1608-1609
TREATMENT OF SEPTIC SHOCK WITH THE TUMOR-NECROSIS-FACTOR RECEPTOR-FC FUSION PROTEIN
Authors: FISHER CJ AGOSTI JM OPAL SM LOWRY SF BALK RA SADOFF JC ABRAHAM E SCHEIN RMH BENJAMIN E
Citation: Cj. Fisher et al., TREATMENT OF SEPTIC SHOCK WITH THE TUMOR-NECROSIS-FACTOR RECEPTOR-FC FUSION PROTEIN, The New England journal of medicine, 334(26), 1996, pp. 1697-1702
CORTICOSTEROID TREATMENT FOR SEPSIS - A CRITICAL-APPRAISAL AND METAANALYSIS OF THE LITERATURE
Authors: CRONIN L COOK DJ CARLET J HEYLAND DK KING D LANSANG MAD FISHER CJ
Citation: L. Cronin et al., CORTICOSTEROID TREATMENT FOR SEPSIS - A CRITICAL-APPRAISAL AND METAANALYSIS OF THE LITERATURE, Critical care medicine, 23(8), 1995, pp. 1430-1439
GUIDELINES FOR RESIDENT PHYSICIAN TRAINING IN CRITICAL CARE MEDICINE
Authors: SPEVETZ A BRILLI RJ WARREN J BAYLY RW CARL L COWEN J DIRINGER MN EGOL AB FISHER CJ GREENBAUM DM HAUPT MT JACOBI J NIKAS DL SCHEIN RMH STONE JR WEDEL SK ZIMMERMAN JE
Citation: A. Spevetz et al., GUIDELINES FOR RESIDENT PHYSICIAN TRAINING IN CRITICAL CARE MEDICINE, Critical care medicine, 23(11), 1995, pp. 1920-1923
RELATIVE CONCENTRATIONS OF ENDOTOXIN-BINDING PROTEINS IN BODY-FLUIDS DURING INFECTION
Authors: OPAL SM PALARDY JE MARRA MN FISHER CJ MCKELLIGON BM SCOTT RW
Citation: Sm. Opal et al., RELATIVE CONCENTRATIONS OF ENDOTOXIN-BINDING PROTEINS IN BODY-FLUIDS DURING INFECTION, Lancet, 344(8920), 1994, pp. 429-431
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME (VOL 271, PG 1836, 1994)
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME (VOL 271, PG 1836, 1994), JAMA, the journal of the American Medical Association, 272(15), 1994, pp. 1170-1170
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC ASTIZ M CARPATI C BONE RC FREIDMAN B MURE AJ BRATHWAITE C SHAPIRO E MELHORN L TAYLOR R KEEGAN M OBRIEN J SCHEIN R PENA M WASSERLOUF M OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAM N MERRICK DK BERGQUIST W MATZEL KE HUEBLER M FOULKE GE ALBERTSON TE WALBY WF ALLEN RP BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMPSON BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C STORER S GERVICH DH FOSHE D BRASE R BAGDAHN A COONEY R SMITH JS MARTIN LF VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN HG DURKIN MR DUBIN PK STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUWEN PAM BOERMEESTER MA SCHNEIDER AJ BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N SILVERSTEIN J ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL JA KRUGER R DRUMMOND A LANGE P SEIFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY SF COYLE SM BARIE PS DEMARIA E SNYDMAN DR SCHWAITZBERG SD NASRAWAY SA GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D CAMPBELL D BLEICHNER G DAHN MS LANGE MPA HALL J POHLMAN A WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON GL SENEFF MG CONRY KM ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D PORTER JC LAURELL MH JACOBS S ASH S STILES DM PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDEMAN H WITTES J CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 271(23), 1994, pp. 1836-1843
ROLE OF INTERLEUKIN-1 AND THE THERAPEUTIC POTENTIAL OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN SEPSIS
Authors: FISHER CJ OPAL SM LOWRY SF SADOFF JC LABRECQUE JF DONOVAN HC LOOKABAUGH JL LEMKE J PRIBBLE JP STROMATT SC VIGERS GP RUSSELL DA THOMPSON RC
Citation: Cj. Fisher et al., ROLE OF INTERLEUKIN-1 AND THE THERAPEUTIC POTENTIAL OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN SEPSIS, Circulatory shock, 44(1), 1994, pp. 1-8
AN EVALUATION OF THE HEMODYNAMIC-EFFECTS OF HA-1A HUMAN MONOCLONAL-ANTIBODY
Authors: KETT DH QUARTIN AA SPRUNG CL FISHER CJ PENA MA HEARD SO ZIMMERMAN JL ALBERTSON TE PANACEK EA EIDELMAN LA SCHEIN RMH
Citation: Dh. Kett et al., AN EVALUATION OF THE HEMODYNAMIC-EFFECTS OF HA-1A HUMAN MONOCLONAL-ANTIBODY, Critical care medicine, 22(8), 1994, pp. 1227-1234
REGIONALIZATION OF CRITICAL CARE MEDICINE - TASK-FORCE REPORT OF THE AMERICAN-COLLEGE-OF-CRITICAL-CARE-MEDICINE
Authors: THOMPSON DR CLEMMER TP APPLEFELD JJ CRIPPEN DW JASTREMSKI MS LUCAS CE POLLACK MM WEDEL SK BAYLY R BEKES C BONNELL B BOWER J BROWN JS BRYANBROWN C BURSCH L DAVILA F DAVIS WR DEPPE SA FALCONE RE FALK J FISER DH FISHER CJ FUHRMAN BP GALLAGHER TJ HAND RW HOYT JW KANTER RK KINCAID D MARTIN CM PETERSON B PRYOR R SCOTT WE SHIN B STONE JR STOTHERT JC WATSON CB WILES CE WLODY G YEH TS
Citation: Dr. Thompson et al., REGIONALIZATION OF CRITICAL CARE MEDICINE - TASK-FORCE REPORT OF THE AMERICAN-COLLEGE-OF-CRITICAL-CARE-MEDICINE, Critical care medicine, 22(8), 1994, pp. 1306-1313
Risultati: 1-25 | 26-38